Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 13, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global biodegradable stents market (Markt für biologisch abbaubare Stents was worth US$ 351.6 Mn in 2023 and is expected to reach US$ 809.2 Mn by the year 2034 at a CAGR of 7.8% between 2024 and 2034.
Bioresorbable stent (BRS) devices, also known as bioabsorbable or biodegradable stents, refer to coronary stents that can fully dissolve in the body. These devices are designed to treat benign strictures in the mid & lower oesophagus and help to facilitate long term stricture remodelling. Moreover, they are manufactured from a material that may dissolve or be absorbed in the body.
A Sneak Peek into Biodegradable Stents Market
Bioresorbable stents present a promising alternative to conventional permanent stents, effectively addressing the challenge of in-stent restenosis, where scar tissue forms beneath the stent, thereby leading to the re-narrowing of a previously opened coronary artery. Unlike metallic stents with a thin drug coating, these naturally dissolving stents can deliver a higher concentration of drugs directly to the target site. Made from biodegradable poly-l-lactic acid (PLLA), these stents offer localized drug delivery and are increasingly used in treating congenital heart disease and the other cardiovascular conditions.
Request for sample copy of report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12464
As a result, the biodegradable stents market is growing rapidly since they overcome the long-term issues raised by metallic stents. Innovations in material science technology, three-dimensional printing, and drug-emitting abilities have made it possible to design and construct biodegradable endos that are safer, more effective, and produce better results for patients. Advanced manufacturing methods for customizing and personalizing biodegradable stents lead to improved treatment results.
The growth and acceptance of markets relies heavily on regulatory support offered by both - clinical trials and their approvals. Nevertheless, cost factors as well as long-term endurance still pose problems. To improve the life span and action of such devices, producers should work on their deterioration rates, mechanical strength, and drug delivery patterns.
Biodegradable stents market opportunities involve expansion due to rising cardiovascular disease rates as well as an increasing population of elderly people. Furthermore there are ongoing R&D investments aimed at improving material properties, drug delivery abilities, and general performance. With changing prospects of tomorrow, current long lasting supports, attention by regulatory bodies, opening rooms for research toward improving technologies are key to its success. Organizations in the marketplace that direct their efforts at allaying fears related to prices while ensuring the longevity of products will likely have a purpose.
In a nutshell, this movement toward biodegradable stents is a substantial change in interventional cardiology providing both - patients and providers with better care services regarding symptoms of coronary artery diseases. These practitioners should always keep a tab on new technologies, rules/regulations, and market trends surrounding them; which will also help to improve patients’ situations during cardiac procedures.
What’s with Bioresorbable Stents Market Regional Insights?
Europe generated the largest market value in 2023. The region is expected to maintain its dominance during the forecast period as well.
Increasing incidence of cardiovascular diseases, particularly coronary artery disease, continuous innovations in stent technology such as improved bioresorbable materials and drug-eluting capabilities, favorable government policies, regulatory approvals, reimbursements for bioresorbable stents, and growing awareness among healthcare professionals and patients about the benefits of bioresorbable stents including reduced risk of long-term complications are some of the factors diving bioresorbable stents market share.
Unlock Growth Potential in Your Industry! Download PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12464
Key Developments
Boston Scientific Corporation, Abbott Laboratories, Elixir Medical Corporation, KYOTO MEDICAL PLANNING CO., Ltd., Biotronik, Terumo Corporation, Biosensors International Group, ELLA – CS, s.r.o., and SMT are some of the leading key players operating in the global industry.
- In March 2024, SafeGuard Surgical, a leading medical technology company focused on life-saving biodegradable solutions, announced a major milestone in its mission to improve global healthcare. The U.S. Food and Drug Administration (FDA) has granted "Breakthrough" designation to SafeGuard Surgical's patented biodegradable stent, LeakGuardTM. This rare honor and recognition by the FDA has been bestowed upon approximately 800 medical devices till date.
Biodegradable Stents Market Segmentation
- Stent Type
- Coronary Artery Stents
- Peripheral Artery Stents
- Material Type
- Polymer-based
- Metal-based
- End-user
- Hospitals
- Cardiac Catheterization Laboratories
- Ambulatory Surgery Centers
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=12464<ype=S
More Trending Reports by Transparency Market Research –
The ligament stabilizer market size (Markt für Bänderstabilisatoren) stood at US$ 2.5 billion in 2022. It is expected to increase at a CAGR of 6.7% from 2023 to 2031, reaching US$ 4.6 billion by the end of 2031.
The dental fluoride treatment market (Markt für zahnärztliche Fluoridbehandlung) was valued at US$ 14.1 billion in 2022. It is projected to grow at a CAGR of 4.5% from 2023 to 2031, reaching more than US$ 21.0 billion by the end of 2031.
The asthma spacers market (Markt für Asthma-Abstandshalter) was valued at US$ 1.8 billion in 2022. It is estimated to grow at a CAGR of 4.1% from 2023 to 2031, reaching US$ 2.6 billion by the end of 2031.
The bovine blood plasma derivatives market (Markt für Rinderblutplasma-Derivate) was valued at US$ 1.9 billion in 2022. It is estimated to grow at a CAGR of 5.7% from 2023 to 2031, reaching US$ 3.2 billion by the end of 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
